NBTX
Nanobiotix is a biotechnology company focused on discovering, developing, manufacturing, and commercializing physics-based nanomedicines for cancer therapy. The company specializes in leveraging nanomaterials to enhance radiotherapy and oncology treatments, aiming to improve patient outcomes across international markets. With research and operations spanning global locations, Nanobiotix positions itself at the intersection of nanomedicine and cancer biology, pursuing novel approaches to treatment. The organization emphasizes scientific innovation, clinical development, and partnerships across the biopharma ecosystem.
No recent deals for this company.